Educating and spreading awareness can help reduce behaviors that propagate stigma and dehumanizing treatment of people with ...
Researchers from the Indiana University School of Medicine have developed a highly sensitive diagnostic that predicts a ...
A new predictive tool combining amyloid PET data with key clinical factors estimates an individual’s lifetime risk for mild ...
Our clinical operations teams drove impressive enrollment numbers this year based on strong interest from patients and investigators,” stated Lisa Ricciardi, Cognition’s president and CEO. “During the ...
The cumulative use of strong anticholinergics is associated with an increased risk for dementia in a dose-response pattern; however, weak anticholinergics show no such effect.
The European Medicines Agency (EMA) authorises initiation of a Phase IIa study evaluating AT-001 in patients diagnosed with Alzheimer's disease -- EMA grants Orphan Drug Designation (ODD) to AT-001 ...